All In Biotech

Drug Trial Radar · NCT01898273

Imaging Trial With I-124-CLR1404 in Patients With Newly Diagnosed or Recurrent Glioblastoma

Phase 2, Open-Label, Imaging Trial of I-124-CLR1404 in Patients With Newly Diagnosed or Recurrent Glioblastoma

Last checked: Nov 19, 2026Latest source record: Sep 9, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

7

Actual

Start

Feb 2014

Primary completion

Sep 2015

Study completion Dec 2015

Sponsor

Lead sponsor
Cellectar Biosciences, Inc.Industry
Sponsor type
Industry
First posted
Jul 12, 2013

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this trial is to determine the optimal dose and imaging time point(s) of I-124-CLR1404 in subjects with newly diagnosed and recurrent glioma to be used in future trials.

Conditions

  • Glioblastoma

Interventions

  • I-124-CLR1404Drug

    single-dose, intravenous

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Optimal Imaging Parameters - DoseTime frame: 8 days

Locations

9 sites in 1 country. Site status is shown where the registry gives one.

  • City of Hope

    Duarte, California

  • Moffitt Cancer Center and Research Institute

    Tampa, Florida

  • University of Maryland School of Medicine

    Baltimore, Maryland

  • Cleveland Clinic

    Cleveland, Ohio

  • Ohio State University Medical Center

    Columbus, Ohio

  • Kettering Medical Center

    Kettering, Ohio

  • Hospital of University of Pennsylvania

    Philadelphia, Pennsylvania

  • University of Wisconsin

    Madison, Wisconsin

  • Medical College of Wisconsin

    Milwaukee, Wisconsin

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.